The use of dopamine in Takotsubo cardiomyopathy

International Journal of Cardiology

Volumn 145, Issue 1, 2010, Pages 132-

  Tamura, Akira ^a   Abe, Yusei ^b   Kadota, Junichi ^a  

^a OITA UNIVERSITY   (Japan)

^b Almeida Memorial Hospital   (Japan)

Author keywords

Cardiogenic shock; Dopamine; Takotsubo cardiomyopathy

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; PHENYLEPHRINE;

CARDIOGENIC SHOCK; DRUG EFFECT; HEART VENTRICLE PRESSURE; HUMAN; HYPOTENSION; LETTER; PRIORITY JOURNAL; TAKOTSUBO CARDIOMYOPATHY;

EID: 78049483278     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.08.016     Document Type: Article

References (6)

1. Rathakrishnan R, Lee YP. The use of vasopressors in Takotsubo cardiomyopathy: impact on neurological. Int J Cardiol 2009 Jul 18 [Electronic publication ahead of print].
2. Abe Y, Tamura A, Kadota J. Prolonged cardiogenic shock caused by a high-dose intravenous administration of dopamine in a patient with takotsubo cardiomyopathy. Int J Cardiol 2009 Jan 8 [Electronic publication ahead of print].
3. A.R. Lyon, P.S. Rees, S. Prasad, PA Poole-Wilson, and SE Harding Stress (Takotsubo) cardiomyopathy-a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning Nat Clin Pract Cardiovasc Med 5 2008 22 29
4. R.P. Villareal, A. Achari, S. Wilansky, and JM. Wilson Anteroapical stunning and left ventricular outflow tract obstruction Mayo Clin Proc 76 2001 79 83
5. M. Kyuma, K. Tsuchihashi, Y. Shinshi, M Hase, T Nakata, and H Ooiwa Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy)-three cases Circ J 66 2002 1181 1184
6. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150